$6.24
0.132.13%
Neuraxis Inc (NRXS) Stock Price, Quote, News & History
NRXSAMEX
NeurAxis Inc (NYSE: NRXS) announced the publication of a Prospective study evaluating the efficacy of IB-Stim in children featured in the September 2023...
You can purchase shares of Neuraxis (AMEX:NRXS) through any online brokerage.
Other companies in Neuraxis’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Neuraxis has a consensus price target of $13.00.
The stock price for Neuraxis (AMEX: NRXS) is $ last updated .
There are no upcoming dividends for Neuraxis.
Neuraxis does not have any upcoming earnings scheduled.
There is no upcoming split for Neuraxis.
Neuraxis is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the AMEX.
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in...
